Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

AEA-[3siRNA-N-protein]-Glc nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

N-(15-azido-14,14-bis(azidomethyl)-3,6,9,12-tetraoxapentadecan)arachidonoylamide

Type Single Compound
Formula C33H56N10O5
Role core
2

siRNA

Type Biomolecule
Formula
Role layer
3

siRNA

Type Biomolecule
Formula
Role layer

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
human T lymphocyte (Jurcat) cells infected with neurotropic rabies virus (RABV)

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • siRNA
  1. GX1gDkYcX4jxHCXAVwE
Product

AEA-[3siRNA-N-protein]-Glc nanoparticles

Size: not specified

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • siRNA
  1. GSLvtwestpXxhe4Geny
Product

AEA-[3siRNA-N-protein]-Glc nanoparticles

Size: not specified

Medium/Support: none

Method 3

Type: Chemical synthesis
Source:
Starting materials
  • siRNA
  1. YntFGAlI9pne3ovVV7I
Product

AEA-[3siRNA-N-protein]-Glc nanoparticles

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial